journal article·2014-03

Preparation and characterization of native poly(3-hydroxybutyrate) microspheres from Bacillus subtilis MTCC 9763

S Saranya, KV Radha

Publisher page

Abstract

Poly(3-hydroxybutyrate) is a biodegradable and biocompatible polymer with many potential biomedical applications including medical implants and drug delivery systems. In this study, poly(3-hydroxybutyrate) production by Bacillus subtilis MTCC 9763 was optimized for different physical and chemical parameters. A 90% poly(3-hydroxybutyrate) accumulation was achieved with 2% fructose and 0.5% ammonium sulfate as carbon and nitrogen sources. The effective accumulation occurred at pH 7. The poly(3-hydroxybutyrate) content of dry cell weight increased to 87% at 36 h of incubation. The synthesized poly(3-hydroxybutyrate) was characterized by Fourier transform infrared and nuclear magnetic resonance spectroscopies. The oil-in-water solvent evaporation technique was used to fabricate the poly(3-hydroxybutyrate) microspheres. The surface morphology appeared smooth in the range of 1–2 µm with specific surface area ranging 19 to 20 m 2 /g. The synthesized poly(3-hydroxybutyrate) microspheres were nontoxic and exhibited good cytocompatibility toward NIH 3T3 fibroblasts.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: biodegradable polymer synthesis and properties · Electrospun Nanofibers in Biomedical Applications · Enzyme Catalysis and Immobilization

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemical Engineering, A.C. Tech, Anna University, Chennai, India

References (35)

Show source-provided references
1. 10.1128/mr.54.4.450-472.199010.1128/mr.54.4.450-472.1990 ↗
2. Korsatko VW · Pharm Ind · 1984 · 46 · 952
3. 10.1016/0169-409X(95)00092-L10.1016/0169-409X(95)00092-L ↗
4. 10.1177/088391150809279010.1177/0883911508092790 ↗
5. 10.1177/088391150910579610.1177/0883911509105796 ↗
6. 10.3390/1001014610.3390/10010146 ↗
7. 10.1177/088391150708840010.1177/0883911507088400 ↗
8. 10.3109/1071754980905203210.3109/10717549809052032 ↗
9. 10.1016/j.jconrel.2004.10.01610.1016/j.jconrel.2004.10.016 ↗
10. 10.1016/S0168-3659(98)00195-310.1016/S0168-3659(98)00195-3 ↗
11. 10.1590/S0103-5053200800050001610.1590/S0103-50532008000500016 ↗
12. 10.1016/j.jconrel.2004.07.00710.1016/j.jconrel.2004.07.007 ↗
13. Schlegel HG · Arch Microbiol · 1970 · 71 · 283
14. 10.1111/j.1472-765X.1990.tb00084.x10.1111/j.1472-765X.1990.tb00084.x ↗
15. 10.1128/AEM.44.1.238-241.198210.1128/AEM.44.1.238-241.1982 ↗
16. Aslim B · J Biotechnol · 2002 · 12 · 24
17. 10.1007/s00253-002-0986-810.1007/s00253-002-0986-8 ↗
18. 10.1007/s11814-013-0169-610.1007/s11814-013-0169-6 ↗
19. Wu Q · Int J Gen Mol Microbiol · 2001 · 80 · 111
20. 10.1007/BF0025759810.1007/BF00257598 ↗
21. 10.1007/s00284990043710.1007/s002849900437 ↗
22. 10.1002/1521-3846(200207)22:3/4<261::AID-ABIO261>3.0.CO;2-M10.1002/1521-3846(200207)22:3/4<261::AID-ABIO261>3.0.CO;2-M ↗
23. 10.1007/s00253005142710.1007/s002530051427 ↗
24. 10.1016/j.biortech.2009.08.04010.1016/j.biortech.2009.08.040 ↗
25. 10.1111/j.1365-2672.2007.03678.x10.1111/j.1365-2672.2007.03678.x ↗
26. 10.1016/S0142-9612(00)00178-210.1016/S0142-9612(00)00178-2 ↗
27. 10.1016/S0169-409X(00)00136-810.1016/S0169-409X(00)00136-8 ↗
28. 10.1016/S0169-409X(03)00037-110.1016/S0169-409X(03)00037-1 ↗
29. 10.1007/978-1-4684-5185-6_1810.1007/978-1-4684-5185-6_18 ↗
30. 10.1016/0731-7085(95)01276-Q10.1016/0731-7085(95)01276-Q ↗
31. 10.1016/j.ijpharm.2004.11.02710.1016/j.ijpharm.2004.11.027 ↗
32. 10.1177/088391151143251110.1177/0883911511432511 ↗
33. 10.1177/088391151244606010.1177/0883911512446060 ↗
34. 10.1002/mabi.20070002210.1002/mabi.200700022 ↗
35. 10.1016/S0142-9612(02)00220-X10.1016/S0142-9612(02)00220-X ↗